A report on patients with glioblastoma indicated that while cytoplasmic survivin levels did not have any effect on prognosis, nuclear survivin localization correlated with significantly lower survival rate than that of patients with low nuclear survivin levels [86]. This evidence concerns the gene BIRC5 and glioblastoma.